Predictive Oncology Inc. (POAI): Price and Financial Metrics

Predictive Oncology Inc. (POAI): $1.61

0.03 (-1.83%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add POAI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#233 of 350

in industry

POAI Price/Volume Stats

Current price $1.61 52-week high $7.12
Prev. close $1.64 52-week low $1.12
Day low $1.58 Volume 7,608
Day high $1.62 Avg. volume 118,382
50-day MA $1.89 Dividend yield N/A
200-day MA $3.01 Market Cap 6.60M

POAI Stock Price Chart Interactive Chart >


Predictive Oncology Inc. (POAI) Company Bio


Predictive Oncology Inc. operates as a biotechnology company. The Company focuses focuses on applying data and artificial intelligence to personalized medicine and drug discovery. Predictive Oncology serves customers worldwide.


POAI Latest News Stream


Event/Time News Detail
Loading, please wait...

POAI Latest Social Stream


Loading social stream, please wait...

View Full POAI Social Stream

Latest POAI News From Around the Web

Below are the latest news stories about PREDICTIVE ONCOLOGY INC that investors may wish to consider to help them evaluate POAI as an investment opportunity.

Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

Company to host investor call and webcast today, November 14th, at 8:30am EDTPITTSBURGH, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility, to accelerate oncologic drug discovery and enable drug development, today reported financial and operating results for the three and nine months ended Sep

Yahoo | November 14, 2023

Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital

PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study with UPMC Magee-Womens Hospital. The objective of the study was to evaluate the use of AI to build multi-omic machine learning (ML) models and test if these models can learn associations between the datasets and ovarian cancer patient short- and long-term survival. “This study incorporated one of the la

Yahoo | November 8, 2023

Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023

Management to host conference call and webcast at 8:30am EDTEAGAN, Minn., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced that

Yahoo | November 7, 2023

3 AI Stocks Worth Buying Now for Multibagger Returns

With no signs of artificial intelligence cooling, we could be looking at a potential $1.8 trillion opportunity for AI stocks.

Ian Cooper on InvestorPlace | October 10, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting the final day of trading this week with a dive into the biggest pre-market stock movers worth watching for Friday!

William White on InvestorPlace | August 18, 2023

Read More 'POAI' Stories Here

POAI Price Returns

1-mo 36.44%
3-mo -54.13%
6-mo -46.51%
1-year -48.89%
3-year -92.94%
5-year -98.55%
YTD -51.06%
2023 -46.35%
2022 -67.79%
2021 29.97%
2020 -71.94%
2019 -57.90%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!